ClinicalTrials.gg
RecruitingNCT05028972HearVA-EDUpdated Oct 5, 2026

Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

An interventional study of Personal Amplifier and No Personal Amplifier in Hearing Loss, Emergency Service and Hospital Readmission, sponsored by VA Office of Research and Development. Recruiting at 6 sites in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2021; still recruiting 4 years 11 months later.
Updated Oct 5, 2026Site recruiting status changedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,050
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Hearing Loss by VA Office of Research and Development — 3 open to participants now, 3 under way, none of them phase 3. Hearing Loss · VA Office of Research and Development.

Planned enrollment
Largest of 13
1,050 · median 84
Started
2021
the only one that year
No phase
13 of 16
3 open now
Registered
14th of 16
by date

Among the 16 studies in Hearing Loss by VA Office of Research and Development, this one has the largest planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2021, is one of 13 with no phase, and was the 14th registered.

Hearing Loss

797 studies on the registry are indexed under Hearing Loss; 194 are open to participants now.

Browse Hearing Loss studies →

Open to participants now

3 of the 16 studies in Hearing Loss by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 125 Hearing Loss studies recruiting now, 60 (48%) set no upper age limit and 43 (34%) stop at 75 or younger; 47 take children under 18; 46 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Hearing Loss by VA Office of Research and Development, or all of them as a file.
02

Study summary

HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.

Read the detailed description

HearVA is a randomized controlled trial to explore the utility and outcomes of providing point-of-care access to hearing-impaired Veterans, comparing an offer of personal amplifiers versus control in an environment where the clinical stakes are high. It addresses a knowledge gap about the utility of providing such hearing assistance during clinical encounters. The study measures whether providing personal amplifiers is acceptable to older patients, can improve hearing, enhance understanding of discharge instructions, and improve care transitions at discharge. If such a strategy is beneficial, this simple low-tech approach has great potential for implementation and wide dissemination. HearVA-ED has two phases - the first, which has been completed, established the feasibility and acceptability of research and procedures in the ED environment through a pilot efficacy study and the second phase will be to complete a larger more definitive efficacy study and a detailed implementation study resulting in a strategic approach that can be widely disseminated across all VA emergency departments throughout the United States. This second phase will use a mixed-methods, hybrid effectiveness-implementation design to implement and evaluate the hearing assistance intervention in six VA Emergency Department Sites (in different facilities across the country). Implementation will occur in four stages with variation in the starting sequence at each site: The first group of two VA emergency departments will initiate implementation with an efficacy trial; second group of two sites will initiate implementation with delivery and support of personal amplifiers after screening and randomization by a research assistant (Stage 1); the third group of two sites will initiate implementation with the entire implementation (Stage 2) and the presence of a research assistant to conduct discharge interviews; and all sites will progress from this sequence to Stage 3 - Sustainability - which is the full implementation without research assistant presence.

03

Conditions studied

  • Hearing Loss
  • Emergency Service
  • Hospital Readmission

Keywords

  • Hearing loss
  • Emergency service
  • ED Revisit
  • Communication
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English speaking
  • Emergency severity index criterion of 3 (medium), 4, or 5 (low acuity)
  • Hearing Handicap Inventory-Screen greater than or equal to 10 or positive answer to a single-item screening question
  • Capacity to consent to participate in research

Exclusion criteria

Exclusion Criteria:

  • Inability to consent to participate in research
  • Emergency severity index criterion of 1-2 (high acuity)
  • Hearing Handicap Inventory-Screen less than 10 and negative answer to single item screening question
  • Inability to speak English
  • Using cochlear implants
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,050 participants (estimated)

Study arms

  • Experimental
    Intervention: Personal Amplifier

    Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department

    Other: Personal Amplifier

  • Other
    Control: No Personal Amplifier

    Consenting participants will be randomly assigned to the control group while receiving care in the emergency department

    Other: No Personal Amplifier

Interventions

  • OtherPersonal Amplifier

    The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED

    Also known as: Pocketalker

  • OtherNo Personal Amplifier

    The control group will not receive personal amplifiers while they receive care in the ED

06

What researchers measure

Primary outcomes

  1. Emergency department (ED) 3-day Readmissions

    The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge

    Time frame: 3-5 days after initial ED stay

Secondary outcomes

  1. Emergency department (ED) 30-day Readmissions

    The Investigators will determine whether patients have had an ED revisit within 30 days through CPRS review as well as a brief follow-up phone call 30-35 days after ED discharge

    Time frame: 30-35 days after initial ED stay

  2. Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) Stay

    Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers.

    Time frame: Duration of ED stay, average of 1 day

  3. Patient-Rated Quality of Post-Discharge Care

    Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation.

    Time frame: At time of discharge from ED, average 1 day

  4. Self-Reported Understanding of Discharge Instructions

    Investigators will gauge self-reported understanding of discharge instructions using semi-structured interview data compared to documented discharge data.

    Time frame: 3-5 days after initial ED stay

07

Study locations

5 of 6 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Mar 2027, 63 months after the start.

Of 197 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 63 months is above that.

Counting every sponsor, half of 323 studies reached it within 19 months; a quarter within 5 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 5, 2026: primary completion Sep 2026 → Mar 2027 and completion Sep 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2021
First posted
Aug 31, 2021
StartActual
Dec 8, 2021
Primary completionEst.
Mar 31, 2027was Sep 2026
CompletionEst.
Mar 31, 2027was Sep 2026
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
2 sites changed recruiting status (1 now active, not recruiting, 1 now recruiting)
Show 2 sites
  • Syracuse VA Medical Center, Syracuse, NY · Syracuse, United StatesNot yet recruiting→Active, not recruiting
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX · Dallas, United StatesNot yet recruiting→Recruiting
Oct 5, 2026
Primary completion
Sep 30, 2026→Mar 31, 2027
Oct 5, 2026
Study completion
Sep 30, 2026→Mar 31, 2027
Oct 5, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedEmergency department (ED) 3-day ReadmissionsTime frame: 3-5 days after initial ED stay
Oct 5, 2026
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedEmergency department (ED) 30-day ReadmissionsTime frame: 30-35 days after initial ED stay
  • EditedPatient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) StayTime frame: Duration of ED stay, average of 1 day
Oct 5, 2026
Site contacts
Changed at 2 sites. See the sites
Show 2 sites
  • VA NY Harbor Healthcare System, New York, NY · New York, United StatesContact T•••@va.gov · •••7500→a•••@va.gov · •••7500
  • Syracuse VA Medical Center, Syracuse, NY · Syracuse, United StatesContact removed K•••@va.gov · •••4400
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    2 sites changed recruiting status (1 now active, not recruiting, 1 now recruiting)
    Show 2 sites
    • Syracuse VA Medical Center, Syracuse, NY · Syracuse, United StatesNot yet recruiting→Active, not recruiting
    • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX · Dallas, United StatesNot yet recruiting→Recruiting
    Primary completion Sep 30, 2026→Mar 31, 2027
    Study completion Sep 30, 2026→Mar 31, 2027
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedEmergency department (ED) 3-day ReadmissionsTime frame: 3-5 days after initial ED stay
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedEmergency department (ED) 30-day ReadmissionsTime frame: 30-35 days after initial ED stay
    • EditedPatient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) StayTime frame: Duration of ED stay, average of 1 day
    Site contacts Changed at 2 sites. See the sites
    Show 2 sites
    • VA NY Harbor Healthcare System, New York, NY · New York, United StatesContact T•••@va.gov · •••7500→a•••@va.gov · •••7500
    • Syracuse VA Medical Center, Syracuse, NY · Syracuse, United StatesContact removed K•••@va.gov · •••4400
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05028972
Collaborators
NYU Langone Health
Responsible party
Sponsor
First posted
Aug 31, 2021
Start date
Dec 8, 2021
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Joshua Chodosh, MD MSHS
Contact
Joshua.Chodosh@va.gov
(310) 478-3711 ext. 48491
Lin T Tun
Contact
lin.tun@va.gov
(646) 501-4132
Joshua Chodosh, MD MSHS
principal investigator · VA NY Harbor Healthcare System, New York, NY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion